Age-Related Macular Degeneration Tied to Heightened Risk for Rheumatoid Arthritis
By Lori Solomon HealthDay Reporter
WEDNESDAY, Oct. 9, 2024 -- Age-related macular degeneration (AMD) is associated with a higher risk for rheumatoid arthritis (RA), according to a study published online Sept. 9 in Scientific Reports.
Je Moon Yoon, from Sungkyunkwan University in Seoul, South Korea, and colleagues examined the association between AMD with and without visual disability (VD) and the risk of RA. Analysis included 3.5 million individuals who underwent health checkups in 2009 with follow-up until 2019.
The researchers found that 1.24 percent of the cohort were diagnosed with RA. There was higher risk of RA among individuals with AMD, compared to controls, regardless of the presence of VD (adjusted hazard ratio [aHR], 1.11; 95 percent confidence interval [CI], 1.02 to 1.21), when adjusting for lifestyle factors and comorbidities. Different risk levels of RA were seen among individuals with AMD based on VD status (without VD: aHR, 1.13; 95 percent CI, 1.03 to 1.21; with VD: aHR, 0.90; 95 percent CI, 0.64 to 1.27).
"In order to interpret our findings showing that the risk of incident RA did not increase in AMD patients with VD, it is necessary to consider the possibility that RA may be underdiagnosed in this population," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-10 12:00
Read more
- Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening
- Kids Still Find It Easy to Buy Flavored Vapes Online
- Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints
- 'Dawson's Creek' Star James Van Der Beek Has Colon Cancer
- More Than Half of Heat Deaths Can Be Blamed on Global Warming: Study
- Primary Care Encounter Notes Often Lack Thoroughness
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions